Drug Database
Back to search

France· FR:64304674

YELLOX 0,9 mg/ml, collyre en solution

A bromfenac product containing bromfénac sodique sesquihydraté, registered in France by BAUSCH + LOMB IRELAND (IRLANDE), on the national reimbursement list. The same ATC class is registered in 15 of our 19 countries.

Reimbursed in France (Assurance maladie)ATC S01BC11

Checked against Base de données publique des médicaments — BDPM (France) on

Informational only — not a medical device.

SOURCE REGISTER · FRBase de données publique des médicament…normalisedYELLOX 0,9 mg/ml, collyre en solutionATCS01BC11REGISTER NO.FR:64304674PACKS LISTED1CHECKEDSeptember 12, 2026
Compare price across countriesPer daily dose · free accountAsk the assistant about bromfénac sodique sesquihydratéAnswers with sources · free accountCheck interactionsSeverity free · mechanism on Growth

Where it is registered

Bromfenac is registered in 15 of 19 countries.

Countries holding a registration under ATC S01BC11 (bromfenac), each read from that country’s own register.

  • This record: France, from Base de données publique des médicaments — BDPM (France)
  • 9 of them publish a price we can compare per daily dose
Search bromfenac products by name

Bromfenac · ATC S01BC11

15 / 19 countries

  • Belgiumprice
  • Canada
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Franceprice
  • Icelandprice
  • Ireland
  • Japan
  • Netherlands
  • Norwayprice
  • Polandprice
  • Switzerlandprice
  • United Kingdom
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

Base de données publique des médicaments — BDPM (France)
Active substance
BROMFÉNAC SODIQUE SESQUIHYDRATÉ
Manufacturer
BAUSCH + LOMB IRELAND (IRLANDE)
Country
France (FR)
ATC code
S01BC11
ATC class
Bromfenac
Defined daily dose
66 mcg, AT
Reimbursed
Yes
Source register
Base de données publique des médicaments — BDPM (France)
Last checked
September 12, 2026

Packs & prices · 1

1 priced
  • cip13
    3400921604696
    1 flacon(s) polyéthylène de 5 ml avec compte-gouttes
    EUR 3.57

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

200 interactions on record for bromfenac.

Graded by severity as the source publishes them — 53 severe. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan
Check bromfenac against other medicinesHow interaction checks work

Bromfenac · interactions on record

200 records

  • 53 severe
  • 145 moderate
  • 2 minor

Most severe, free to view

  • WarfarinB01AA03severe
  • DalteparinB01AB04severe
  • EnoxaparinB01AB05severe
  • PrasugrelB01AC22severe
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Bromfenac in 14 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All bromfenac products

Authorised across Europe · EMA

The same active substance is authorised in 14 EEA countries. Names it is sold under:

  • Cyprus · Eyebrom
  • Czechia · Bromfenac Olikla
  • Spain · Alcarix, Eyebrom
  • Finland · Bromfenac
  • United Kingdom (Northern Ireland) · Bromfenac Aspire Pharma, Yellox
  • Greece · Eyebrom
  • Iceland · Yellox
  • Italy · Bromoftil, Coxafen
  • Liechtenstein · Yellox
  • Netherlands · Bromfenac, Broomfenac Ntc
  • Norway · Bromfenac Blumont, Yellox
  • Poland · Brofestill, Bromfenacum Brofestill Krople Do Oczu, Roztwór W Pojemniku Jednodawkowym
  • Portugal · Brovit, Katlox
  • Slovakia · Bromfenac Olikla

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Base de données publique des médicaments — BDPM (France). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/5b89b3ac-714d-44c1-9871-6d998a7d6d22
GET /v1/drugs/5b89b3ac-714d-44c1-9871-6d998a7d6d22?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "cis": "64304674",
  "date_amm": "2011-05-18",
  "type_amm": "Procédure centralisée",
  "numero_ue": "EU/1/11/692",
  "substance": "BROMFÉNAC SODIQUE SESQUIHYDRATÉ",
  "atc_source": "fr_atc_restore_2026-09-06",
  "statut_amm": "Autorisation active",
  "statut_bdm": null,
  "forme_pharmaceutique": "collyre en solution",
  "voies_administration": "ophtalmique",
  "etat_commercialisation": "Commercialisée",
  "surveillance_renforcee": "Non"
}
API referenceMCP serverPlans

See everything about bromfenac.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it freeOpen in the console